Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
-
15261
Table_1_A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene.xlsx
Published 2023“…The pathological changes included glomerular atrophy, increased monocytes in renal interstitial, and the absence of type IV collagen α5. The expression of Col4a5 was significantly decreased in Del-ATGG mouse model. …”
-
15262
-
15263
SFN treatment impairs STAT5A-1*6-mediated survival and growth of Ba/F3 cells.
Published 2016“…By contrast, STAT5A-1*6 phosphorylation decreased after 5 days of treatment with 2 μM SFN.…”
-
15264
Characteristics of study participants (N = 788).
Published 2024“…</p><p>Results</p><p>Most respondents were women (65%), retired (71%) and had a mean-age of 70.8 years (SD 11.4). The 7-item version of the Pearlin Mastery Scale showed poor fit to the one factor model. …”
-
15265
-
15266
-
15267
-
15268
-
15269
-
15270
-
15271
-
15272
-
15273
-
15274
-
15275
-
15276
-
15277
-
15278
-
15279
Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis
Published 2016“…Pooled analysis revealed significant improvements in FEV<sub>1</sub> (first second forced expiratory volume) (MD = 0.09, 95% CI: 0.06–0.12, <i>I</i><sup><i>2</i></sup> = 10%), FEV<sub>1</sub>% (MD = 3.75, 95% CI: 1.66–5.83, <i>I</i><sup><i>2</i></sup> = 19%), Asthma Quality of Life Questionnaire (AQLQ) score (MD = 0.22, 95% CI: 0.15–0.30, <i>I</i><sup><i>2</i></sup> = 0%), decreased blood, sputum eosinophils and asthmatic exacerbation (RR = 0.66, 95% CI: 0.59–0.73, <i>I</i><sup><i>2</i></sup> = 51%); peak expiratory flow (PEF) (MD = 5.45, 95% CI: -2.83–13.72, <i>I</i><sup><i>2</i></sup> = 0%), histamine PC<sub>20</sub> (MD = -0.62, 95% CI: -1.92–0.68, <i>I</i><sup><i>2</i></sup> = 0%) or SABA rescue use (MD = -0.11, 95% CI: -0.3–0.07, <i>I</i><sup><i>2</i></sup> = 30%) were unaffected; adverse events were not increased (RR = 0.93, 95% CI: 0.89–0.98, <i>I</i><sup><i>2</i></sup> = 46%). …”
-
15280
A Review of Recent Research on Catalytic Biomass Pyrolysis and Low-Pressure Hydropyrolysis
Published 2021“…This review summarizes the myriad of different catalysts studied and benchmarks their deoxygenation performance by also taking into account the resulting decrease in bio-oil yield compared to a thermal pyrolysis oil. …”